M. ALKAN MELİKOĞLU And E. BALKAN, "Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study," INFLAMMOPHARMACOLOGY , vol.30, no.1, pp.193-197, 2022
ALKAN MELİKOĞLU, M. And BALKAN, E. 2022. Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study. INFLAMMOPHARMACOLOGY , vol.30, no.1 , 193-197.
ALKAN MELİKOĞLU, M., & BALKAN, E., (2022). Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study. INFLAMMOPHARMACOLOGY , vol.30, no.1, 193-197.
ALKAN MELİKOĞLU, Meltem, And Eda BALKAN. "Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study," INFLAMMOPHARMACOLOGY , vol.30, no.1, 193-197, 2022
ALKAN MELİKOĞLU, Meltem A. And BALKAN, Eda. "Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study." INFLAMMOPHARMACOLOGY , vol.30, no.1, pp.193-197, 2022
ALKAN MELİKOĞLU, M. And BALKAN, E. (2022) . "Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study." INFLAMMOPHARMACOLOGY , vol.30, no.1, pp.193-197.
@article{article, author={Meltem ALKAN MELİKOĞLU And author={Eda BALKAN}, title={Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study}, journal={INFLAMMOPHARMACOLOGY}, year=2022, pages={193-197} }